AAV-CMV-mRFP (AAV Serotype 1)

Product Category:
Pre-made recombinant AAV | AAV-CMV-RFP | AAV-RFP | AAV1-CMV-mRFP | AAV1-RFP
Description:
AAV1-CMV-mRFP is a pre-packaged recombinant AAV based on serotype 1, containing an AAV1 capsid and AAV2 inverted terminal repeats (ITRs). It drives expression of monomeric red fluorescent protein (mRFP) under the control of the CMV promoter. The mRFP is a monomeric variant of Discosoma (DsRed), designed to eliminate tetramerization and reduce cellular toxicity. This vector is ideal for use as a fluorescent reporter in target cells. Supplied in a ready-to-use format, it enables efficient and reproducible gene expression studies in vitro and in vivo.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL at >10¹³ VG/mL, 10 µL at >10¹³ VG/mL |
Customers who bought this product also purchased…
-
SL100867AAV-CMV-mRFP (AAV Serotype 9)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100803AAV-GFP (AAV Serotype 1)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100870AAV-CMV-mRFP (AAV Serotype 8)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100859AAV-mRFP (AAV Serotype 6)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100853AAV-CMV-mRFP (AAV Serotype 2)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100856AAV-CMV-mRFP (AAV Serotype 5)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.

